Dawaa Reference

chronic

Vocal Cord Polyp

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources3 sources

ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class RD99.06 - condition scope only, no dose · No dose - referral pathway, no medicine given in primary care · Vestibular Schwannoma - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK562312/

Verified against1 document
  • No dose - referral pathway, no medicine given in primary care

Verified date2026-08

1

NO DRUG THERAPY IN PRIMARY CARE (REFERRAL & ADVICE)

1st line
Adult dose and duration

A benign growth on the vocal cord, often from voice overuse or smoking, causing persistent hoarseness; managed with voice rest, speech therapy, and ENT referral for microlaryngoscopy and removal if it does not improve, since there is no drug treatment. - Refer, with advice

Paediatric dose

Children follow the same pathway: recognise and refer. No primary-care medicine is implied.

Dose source

No dose - referral pathway, no medicine given in primary care

Why

A benign growth on the vocal cord, often from voice overuse or smoking, causing persistent hoarseness; managed with voice rest, speech therapy, and ENT referral for microlaryngoscopy and removal if it does not improve, since there is no drug treatment.

Cautions
  • No medicine is prescribed for this in primary care - this entry is for recognition and referral. Anything given is decided by the service it is referred to.
  • RED FLAG - Hoarseness persisting beyond three weeks, especially in a smoker, needs ENT assessment to exclude laryngeal cancer.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.